The Life Sciences Law Review - 7th Edition

The Life Sciences Law Review - 7th Edition

Pages: 556

ISBN: 978-1-912228-19-5



  • £350.00

The Life Sciences Law Review provides an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies. It is vitally important that lawyers who advise companies in the life sciences sector and the business executives whom they serve have a working knowledge of the regulations and policies that govern drugs, biologics and medical devices. It is equally important to keep up to date with developments in the regulatory systems, which govern access to the market, pricing and reimbursement, advertising and promotion, and numerous other matters that are essential to success. It is our hope that this annual publication will be helpful in this respect.

In this book: 

Overviews

  • Editor’s Preface
    • Richard Kingham, Covington & Burling LLP
  • International Harmonisation
    • Richard Kingham, Covington & Burling LLP
  • Latin America Overview
    • Felipe Coronel, Latin Lex Consulting

Countries

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • China
  • Czech Republic
  • Denmark
  • European Union
  • Finland
  • France
  • India
  • Ireland
  • Italy
  • Japan
  • Korea
  • Mexico
  • Norway
  • Peru
  • Poland
  • Portugal
  • Russia
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Arab Emirates
  • United Kingdom
  • United States
  • Venezuela

Richard Kingham, Covington & Burling LLP

Richard Kingham is a senior counsel at Covington & Burling LLP, where he serves as co-head of the life sciences industry group. He previously served as the managing partner of the firm’s London office and as a member of the firm-wide management committee. Since joining the firm in 1973, he has concentrated on regulation of pharmaceuticals and related products. He has acted for most of the major pharmaceutical and biotechnology companies in the United States and Europe, as well as the principal trade associations of the pharmaceutical industry. He has served on committees of the World Health Organization, the Center for Global Development, the Institute of Medicine of the US National Academy of Sciences and the National Institutes of Health. He is currently an adjunct professor at the Georgetown University Law Center, and has lectured at the University of Virginia School of Law and the graduate programme in pharmaceutical medicine at Cardiff University. He received his law degree in 1973 from the University of Virginia, where he served as articles editor of the law review and was elected to the Order of the Coif (the law school honour society).


We Also Recommend